Mixed
Bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy, or gastric banding) significantly improves Type 2 Diabetes (T2DM) remission rates, glycemic control (HbA1c, fasting plasma glucose), and weight loss compared to non-surgical medical management.
For patients with Type 2 Diabetes, bariatric surgery (such as gastric bypass or sleeve gastrectomy) is significantly more effective than standard medical management (diet, exercise, medication) at achieving diabetes remission and improving metabolic health markers like HbA1c and weight loss. While surgery carries higher short-term adverse event risks, these are often benign, and long-term data suggests fewer diabetes-related complications compared to medical therapy alone. Patients should consider surgery as a highly efficacious option for remission, not just weight loss, especially if medical management fails to control the disease.
Compared with non-surgical treatment group, bariatric surgery group was associated with higher rate T2DM remission (RR = 5.76, 95%CI:3.15-10.55, P < 0.00001), more reduction HbA1C (MD = 1.29, 95%CI: -1.70 to -0.87, P < 0.00001), more decrease fasting plasma glucose (MD = -36.38, 95%CI: -51.76 to -21.01, P < 0.00001), greater loss body weight (MD = -16.93, 95%CI: 19.78 to -14.08, P < 0.00001)...
Why this rating
Based on a meta-analysis of 8 Randomized Controlled Trials (RCTs) with 619 patients, though limited by small sample sizes in individual studies and lack of blinding.
Source
Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus
Guozhong Wu et al. · Oncotarget · 2016
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →